Literature DB >> 4246139

Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise.

B G Gatmaitan, J L Chason, A M Lerner.   

Abstract

Coxsackievirus B-3 myocardiopathy was induced in weanling mice by intraperitoneal and intracerebral inoculations of the Nancy strain. Acute mortality was 5.5%. The cardiomyopathy is characterized by an early phase lasting about 9 days with myocardial necrosis, associated inflammation, and healing by fibrosis and calcification involving 25 to 50% of the contractile fibers in each affected mouse. Infectious coxsackievirus may be recovered from the heart during this phase. Continuing myocardial inflammatory lesions follow during the later phase, but infectious virus is no longer present. When mice were forced to swim in a preheated pool (33 degrees C) during both phases of their myocardiopathy, virulence was strikingly augmented. Fully half of the mice died of congestive failure, the majority while swimming. Hearts were dilated, hypertrophied, and grossly necrotic. The myocardium was transformed to a completely necrotic, inflammatory, calcifying mass. At the peak of the infectious phase, myocardial replication of coxsackievirus was increased 530 times in nurslings which had been forced to swim. Myositis in hind limbs was more frequent, and inflammatory lesions in perirenal and pericardial fat were more severe in the mice which were forced to swim. When swimming was begun on the 9th day after infection, the virulence and lethality (13.8%) of infection were moderately increased.

Entities:  

Mesh:

Year:  1970        PMID: 4246139      PMCID: PMC2138852          DOI: 10.1084/jem.131.6.1121

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Coxsackie A9 myocarditis in adult mice.

Authors:  A M LERNER; J A SHAKA
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

2.  Experimental Coxsackie group B virus infections.

Authors:  E I GRODUMS; G DEMPSTER; W A SPENCER
Journal:  Arch Gesamte Virusforsch       Date:  1963

3.  Myocarditis in experimental Coxsackie B-3 infection.

Authors:  E I GRODUMS; G DEMPSTER
Journal:  Can J Microbiol       Date:  1959-12       Impact factor: 2.419

4.  The age factor in experimental Coxsackie B-3 infection.

Authors:  E I GRODUMS; G DEMPSTER
Journal:  Can J Microbiol       Date:  1959-12       Impact factor: 2.419

5.  Factors influencing host-virus interactions. II. Alteration of Coxsackie virus infection in adult mice by cold.

Authors:  W D BORING; D L WALKER; G M ZU RHEIN
Journal:  Proc Soc Exp Biol Med       Date:  1956-11

6.  The induction of gross myocardial lesions by a Coxsackie (pleurodynia) virus and cortisone.

Authors:  E D KILBOURNE; C B WILSON; D PERRIER
Journal:  J Clin Invest       Date:  1956-04       Impact factor: 14.808

7.  Effect of fatigue on susceptibility of mice to poliomyelitis.

Authors:  H E ROSENBAUM; C G HARFORD
Journal:  Proc Soc Exp Biol Med       Date:  1953 Aug-Sep

8.  Acute poliomyelitis relation of physical activity at the time of onset to the course of the disease.

Authors:  D M HORSTMANN
Journal:  J Am Med Assoc       Date:  1950-01-28

Review 9.  An experimental approach to virus myocarditis.

Authors:  A M Lerner
Journal:  Prog Med Virol       Date:  1965

10.  Age and susceptibility of mice to Coxsackie A viruses.

Authors:  A M LERNER; H S LEVIN; M FINLAND
Journal:  J Exp Med       Date:  1962-04-01       Impact factor: 14.307

View more
  27 in total

1.  Neutrophil function response to aerobic and anaerobic exercise in female judoka and untrained subjects.

Authors:  B Wolach; B Falk; R Gavrieli; E Kodesh; A Eliakim
Journal:  Br J Sports Med       Date:  2000-02       Impact factor: 13.800

2.  Around Pediheart: rest and rheumatic fever.

Authors:  F McCaffrey
Journal:  Pediatr Cardiol       Date:  2001 May-Jun       Impact factor: 1.655

3.  Parasitic causes of pericarditis.

Authors:  J A Turner
Journal:  West J Med       Date:  1975-04

4.  Letter: Muscle pain induced by exercise in coxsackie pericarditis.

Authors:  J V Jones
Journal:  Br Med J       Date:  1975-07-12

5.  Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence.

Authors:  R J Kiel; F E Smith; J Chason; R Khatib; M P Reyes
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

Review 6.  Coxsackievirus infection as a trigger of cardiac autoimmunity.

Authors:  L J Wolfgram; N R Rose
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

7.  Site of reovirus replication in liver is determined by the type of hepatocellular insult.

Authors:  D H Rubin; A H Morrison; C L Witzleben; C J Guico; D A Piccoli
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

Review 8.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 9.  [Therapy of dilated cardiomyopathies with and without inflammation].

Authors:  G Hufnagel; S Pankuweit; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

10.  Evaluation of mild acute infectious myocarditis.

Authors:  J Heikkilä; J Karjalainen
Journal:  Br Heart J       Date:  1982-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.